Paper17417639
Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer.
Holst F and 11 others. Nat Genet, 2007. Cited by 286 papers, by iCite.
Cite this record
ConductScience Library. Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer. Papers, record 17417639. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17417639
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Estrogen Receptor alpha | Major topic |
| Gene Amplification | Major topic |
| Base Sequence | |
| Female | |
| Gene Dosage | |
| Humans | |
| Immunohistochemistry | |
| In Situ Hybridization, Fluorescence | |
| Molecular Sequence Data | |
| Polymerase Chain Reaction | |
| Sequence Analysis, DNA |
Source PubMed
Comments and corrections4
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 18583964 | ESR1 gene amplification in breast cancer: a common phenomenon? | https://conductscience.org/library/papers/18583964 | PubMed |
| Comment in | 18583965 | ESR1 gene amplification in breast cancer: a common phenomenon? | https://conductscience.org/library/papers/18583965 | PubMed |
| Comment in | 18583966 | ESR1 gene amplification in breast cancer: a common phenomenon? | https://conductscience.org/library/papers/18583966 | PubMed |
| Comment in | 18583967 | ESR1 gene amplification in breast cancer: a common phenomenon? | https://conductscience.org/library/papers/18583967 | PubMed |
Cited by168
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 286 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42907427 | Actionable genetic landscape and dynamics in circulating DNA from 12,827 patients with metastatic breast cancer. | Nat Commun | 2026 | https://conductscience.org/library/papers/42907427 | PubMed |
| 42645071 | Quantitative Loop-Mediated Isothermal Amplification (qLAMP) for the Rapid Discrimination of Normal and Cancerous Tissue Models: An Arduino-Based Portable Cancer Detection System Assisted by a pH Microelectrode. | Biosensors (Basel) | 2026 | https://conductscience.org/library/papers/42645071 | PubMed |
| 42591592 | Beyond the canonical view: steroid receptor network plasticity and mechanosensitive chromatin integration in breast cancer. | NAR Cancer | 2026 | https://conductscience.org/library/papers/42591592 | PubMed |
| 41571903 | Incorporation of network pharmacology, molecular docking, survival, density functional theory, and experimental studies to explore the potential key targets of formononetin by TERT-mediated anti-cancer effects in MCF-7 breast cancer. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/41571903 | PubMed |
| 41155171 | Computer-Aided Molecular Design Meets Network Toxicology and Molecular Docking: A Joint Strategy to Explore Common Molecular Mechanisms of Phthalates on Human Breast Cancer and Structure-Activity Relationship. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41155171 | PubMed |
| 41062834 | Efficient and precise inversion of genomic DNA from large to chromosomal scale. | Nat Chem Biol | 2026 | https://conductscience.org/library/papers/41062834 | PubMed |
| 39959102 | Efficient and Explainable Virtual Screening of Molecules through Fingerprint-Generating Networks Integrated with Artificial Neural Networks. | ACS Omega | 2025 | https://conductscience.org/library/papers/39959102 | PubMed |
| 39941808 | Heterogeneity in Cancer. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/39941808 | PubMed |
| 39717718 | GATA6 in pancreatic cancer initiation and progression. | Genes Dis | 2025 | https://conductscience.org/library/papers/39717718 | PubMed |
| 39702552 | The EstroGene2.0 database for endocrine therapy response and resistance in breast cancer. | NPJ Breast Cancer | 2024 | https://conductscience.org/library/papers/39702552 | PubMed |
| 39502314 | The relationship between keratin 18 and epithelial-derived tumors: as a diagnostic marker, prognostic marker, and its role in tumorigenesis. | Front Oncol | 2024 | https://conductscience.org/library/papers/39502314 | PubMed |
| 39329990 | Estrogen Regulated Genes Compel Apoptosis in Breast Cancer Cells, Whilst Stimulate Antitumor Activity in Peritumoral Immune Cells in a Janus-Faced Manner. | Curr Oncol | 2024 | https://conductscience.org/library/papers/39329990 | PubMed |
| 38685777 | Envisioning Clinical Management of Breast Cancer: a Comprehensive Review. | Curr Drug Discov Technol | 2025 | https://conductscience.org/library/papers/38685777 | PubMed |
| 38672654 | DNA Damage Responses in Tumors Are Not Proliferative Stimuli, but Rather They Are DNA Repair Actions Requiring Supportive Medical Care. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38672654 | PubMed |
| 38643482 | Estrogen Receptor Alpha Mutations, Truncations, Heterodimers, and Therapies. | Endocrinology | 2024 | https://conductscience.org/library/papers/38643482 | PubMed |
| 38641298 | Androgen receptor and estrogen receptor variants in prostate and breast cancers. | J Steroid Biochem Mol Biol | 2024 | https://conductscience.org/library/papers/38641298 | PubMed |
| 38135758 | Decoding the basis of histological variation in human cancer. | Nat Rev Cancer | 2024 | https://conductscience.org/library/papers/38135758 | PubMed |
| 38066476 | A differential diagnosis between uterine leiomyoma and leiomyosarcoma using transcriptome analysis. | BMC Cancer | 2023 | https://conductscience.org/library/papers/38066476 | PubMed |
| 37929724 | Unveiling the ESR1 Conformational Stability and Screening Potent Inhibitors for Breast Cancer Treatment. | Med Chem | 2024 | https://conductscience.org/library/papers/37929724 | PubMed |
| 37321964 | LINC01116 affects patient survival differently and is dissimilarly expressed in ER+ and ER- breast cancer samples. | Cancer Rep (Hoboken) | 2023 | https://conductscience.org/library/papers/37321964 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ESR1 | 2099 | PubTator's text mining | https://conductscience.org/library/genes/2099 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17417639
GET https://conductscience.org/api/papers/v1/17417639/cited_by?page=2